Literature DB >> 11118460

Interim analyses in clinical trials: why do we plan them?

S D Fossâ, E Skovlund.   

Abstract

Mesh:

Year:  2000        PMID: 11118460     DOI: 10.1200/JCO.2000.18.24.4007

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Systematic review of safety in paediatric drug trials published in 2007.

Authors:  Khairun Nain Bin Nor Aripin; Imti Choonara; Helen M Sammons
Journal:  Eur J Clin Pharmacol       Date:  2011-08-20       Impact factor: 2.953

2.  The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor-Positive Breast Cancer.

Authors:  Ana Elisa Lohmann; Marguerite Ennis; Wendy R Parulekar; Bingshu E Chen; George Tomlinson; Pamela J Goodwin
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.